156 related articles for article (PubMed ID: 15876038)
1. Role of the A-ring of bryostatin analogues in PKC binding: synthesis and initial biological evaluation of new A-ring-modified bryologs.
Wender PA; Clarke MO; Horan JC
Org Lett; 2005 May; 7(10):1995-8. PubMed ID: 15876038
[TBL] [Abstract][Full Text] [Related]
2. Design, synthesis, and biological evaluation of a potent, PKC selective, B-ring analog of bryostatin.
Wender PA; Verma VA
Org Lett; 2006 Apr; 8(9):1893-6. PubMed ID: 16623578
[TBL] [Abstract][Full Text] [Related]
3. Total synthesis and initial biological evaluation of new B-ring-modified bryostatin analogs.
Wender PA; Horan JC; Verma VA
Org Lett; 2006 Nov; 8(23):5299-302. PubMed ID: 17078702
[TBL] [Abstract][Full Text] [Related]
4. Identification of a tunable site in bryostatin analogs: C20 Bryologs through late stage diversification.
Wender PA; Baryza JL
Org Lett; 2005 Mar; 7(6):1177-80. PubMed ID: 15760168
[TBL] [Abstract][Full Text] [Related]
5. Synthesis and PKC binding of a new class of a-ring diversifiable bryostatin analogues utilizing a double asymmetric hydrogenation and cross-coupling strategy.
Wender PA; Horan JC
Org Lett; 2006 Sep; 8(20):4581-4. PubMed ID: 16986955
[TBL] [Abstract][Full Text] [Related]
6. Synthesis of a simplified bryostatin C-ring analogue that binds to the CRD2 of human PKC-alpha and construction of a novel BC-analogue by an unusual Julia olefination process.
Hale KJ; Frigerio M; Manaviazar S; Hummersone MG; Fillingham IJ; Barsukov IG; Damblon CF; Gescher A; Roberts GC
Org Lett; 2003 Feb; 5(4):499-502. PubMed ID: 12583753
[TBL] [Abstract][Full Text] [Related]
7. Simplified analogs of bryostatin with anticancer activity display greater potency for translocation of PKCdelta-GFP.
Baryza JL; Brenner SE; Craske ML; Meyer T; Wender PA
Chem Biol; 2004 Sep; 11(9):1261-7. PubMed ID: 15380186
[TBL] [Abstract][Full Text] [Related]
8. Late-stage intermolecular CH activation for lead diversification: a highly chemoselective oxyfunctionalization of the C-9 position of potent bryostatin analogues.
Wender PA; Hilinski MK; Mayweg AV
Org Lett; 2005 Jan; 7(1):79-82. PubMed ID: 15624982
[TBL] [Abstract][Full Text] [Related]
9. Total synthesis and biological evaluation of potent analogues of dictyostatin: modification of the C2-C6 dienoate region.
Paterson I; Gardner NM; Guzmán E; Wright AE
Bioorg Med Chem Lett; 2008 Dec; 18(23):6268-72. PubMed ID: 18951787
[TBL] [Abstract][Full Text] [Related]
10. A new synthetic approach to the C ring of known as well as novel bryostatin analogues.
Wender PA; Koehler MF; Sendzik M
Org Lett; 2003 Nov; 5(24):4549-52. PubMed ID: 14627380
[TBL] [Abstract][Full Text] [Related]
11. Total synthesis and biological evaluation of (+)-neopeltolide and its analogues.
Fuwa H; Saito A; Naito S; Konoki K; Yotsu-Yamashita M; Sasaki M
Chemistry; 2009 Nov; 15(46):12807-18. PubMed ID: 19882704
[TBL] [Abstract][Full Text] [Related]
12. Function oriented synthesis: the design, synthesis, PKC binding and translocation activity of a new bryostatin analog.
Wender PA; Baryza JL; Brenner SE; Clarke MO; Craske ML; Horan JC; Meyer T
Curr Drug Discov Technol; 2004 Jan; 1(1):1-11. PubMed ID: 16472215
[TBL] [Abstract][Full Text] [Related]
13. Total syntheses of bryostatins: synthesis of two ring-expanded bryostatin analogues and the development of a new-generation strategy to access the C7-C27 fragment.
Trost BM; Yang H; Dong G
Chemistry; 2011 Aug; 17(35):9789-805. PubMed ID: 21780195
[TBL] [Abstract][Full Text] [Related]
14. Enantioselective formal total synthesis of the antitumor macrolide bryostatin 7.
Manaviazar S; Frigerio M; Bhatia GS; Hummersone MG; Aliev AE; Hale KJ
Org Lett; 2006 Sep; 8(20):4477-80. PubMed ID: 16986929
[TBL] [Abstract][Full Text] [Related]
15. A convergent ring-closing metathesis approach to carbohydrate-based macrolides with potential antibiotic activity.
Blom P; Ruttens B; Van Hoof S; Hubrecht I; Van der Eycken J; Sas B; Van hemel J; Vandenkerckhove J
J Org Chem; 2005 Nov; 70(24):10109-12. PubMed ID: 16292849
[TBL] [Abstract][Full Text] [Related]
16. Lobatamide C: total synthesis, stereochemical assignment, preparation of simplified analogues, and V-ATPase inhibition studies.
Shen R; Lin CT; Bowman EJ; Bowman BJ; Porco JA
J Am Chem Soc; 2003 Jul; 125(26):7889-901. PubMed ID: 12823009
[TBL] [Abstract][Full Text] [Related]
17. Total synthesis and biological evaluation of amphidinolide V and analogues.
Fürstner A; Flügge S; Larionov O; Takahashi Y; Kubota T; Kobayashi J
Chemistry; 2009; 15(16):4011-29. PubMed ID: 19241434
[TBL] [Abstract][Full Text] [Related]
18. Toward a biorelevant structure of protein kinase C bound modulators: design, synthesis, and evaluation of labeled bryostatin analogues for analysis with rotational echo double resonance NMR spectroscopy.
Loy BA; Lesser AB; Staveness D; Billingsley KL; Cegelski L; Wender PA
J Am Chem Soc; 2015 Mar; 137(10):3678-85. PubMed ID: 25710634
[TBL] [Abstract][Full Text] [Related]
19. Synthetic studies on the bryostatins: preparation of a truncated BC-ring intermediate by pyran annulation.
Keck GE; Truong AP
Org Lett; 2005 May; 7(11):2149-52. PubMed ID: 15901156
[TBL] [Abstract][Full Text] [Related]
20. Selective binding of bryostatin analogues to the cysteine rich domains of protein kinase C isozymes.
Wender PA; Lippa B; Park CM; Irie K; Nakahara A; Ohigashi H
Bioorg Med Chem Lett; 1999 Jun; 9(12):1687-90. PubMed ID: 10397502
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
